Sorry!! The article you are trying to read is not available now.
Thank you very much;
you're only a step away from
downloading your reports.

$IGC Files 8k Releasing Official Executive Summary

By

PrintPRINT

This article is published in collaboration with Scutify, where you can find real-time markets and stock commentary from Robert Marcin, Cody Willard and others. Download the Scutify iOS App, the Scutify Android App or visit Scutify.com.

India Globalization Capital (IGC) released a company update/executive summary containing new information, specifically regarding its product portfolio and future business initiatives. IGC's mission is to develop, patent, test, and commercialize cannabis-based pharmaceutical, nutraceutical, and veterinary medicines.

Company Background and Assets

· Since 2014, IGC has focused on developing patentable cannabinoid products with a focus on combination therapy and veterinary medicine. IGC's most exciting products in development target Alzheimer's, Parkinson's, and pain.

· The company currently has 10 human and veterinary cannaceutical products currently in development across many disease areas including epilepsy, PTSD, cachexia, pain, Parkinson's, and Alzheimer's. IGC has filed six patents for these therapies.

· In March, IGC filed of a provisional patent (IGC-506) for the treatment of multiple types of eating disorders by a method and combination of cannabis extracts and other compounds. IGC-506 is being developed for both human and veterinary use, should this filing progress to the issuance of a patent.

· IGC has started a review of international medical facilities to commence preclinical and clinical trials in support of its patent portfolio, which includes IGC-501 for neuropathic pain; IGC-502 for the treatment of seizures; and IGC-504 for eating disorders, including cachexia.

The offical 8k via the SEC's website can be found HERE.


This article was written by Mark Maulden for https://technical420.com/cannabis-article/igc-files-8k-releasing-official-executive-summary on .

This article published in collaboration with Scutify, the best app for traders and investors. Download the Scutify iOS App, the Scutify Android App or visit Scutify.com.

< Previous
  • 1
Next >
PrintPRINT
 
Featured Videos

WHAT'S POPULAR IN THE VILLE